Tau PET provides in vivo characterisation of tau pathology, offering crucial insights into Alzheimer’s disease and related disorders (ADRD). This article describes an evidence-based approach to the review and reporting of tau PET in ADRD, aligned with recent international consensus guidelines. We describe visual interpretation using validated scoring systems and harmonising thresholds for quantitative analysis for structured reporting. Implementing a standardised practice enhances reproducibility and clinical decision-making, preparing tau PET for routine clinical use.
Orunmuyi et al. (Sun,) studied this question.